Copper in Gynecological Diseases
-
Published:2023-12-17
Issue:24
Volume:24
Page:17578
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Conforti Rocío A.1ORCID, Delsouc María B.1ORCID, Zorychta Edith2, Telleria Carlos M.23ORCID, Casais Marilina1
Affiliation:
1. Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis (UNSL), Instituto Multidisciplinario de Investigaciones Biológicas de San Luis (IMIBIO-SL-CONICET), San Luis CP D5700HHW, Argentina 2. Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada 3. Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC H4A 3J1, Canada
Abstract
Copper (Cu) is an essential micronutrient for the correct development of eukaryotic organisms. This metal plays a key role in many cellular and physiological activities, including enzymatic activity, oxygen transport, and cell signaling. Although the redox activity of Cu is crucial for enzymatic reactions, this property also makes it potentially toxic when found at high levels. Due to this dual action of Cu, highly regulated mechanisms are necessary to prevent both the deficiency and the accumulation of this metal since its dyshomeostasis may favor the development of multiple diseases, such as Menkes’ and Wilson’s diseases, neurodegenerative diseases, diabetes mellitus, and cancer. As the relationship between Cu and cancer has been the most studied, we analyze how this metal can affect three fundamental processes for tumor progression: cell proliferation, angiogenesis, and metastasis. Gynecological diseases are characterized by high prevalence, morbidity, and mortality, depending on the case, and mainly include benign and malignant tumors. The cellular processes that promote their progression are affected by Cu, and the mechanisms that occur may be similar. We analyze the crosstalk between Cu deregulation and gynecological diseases, focusing on therapeutic strategies derived from this metal.
Funder
Universidad Nacional de San Luis (UNSL), Argentina Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), Argentina Health Canada to Ovarian Cancer Canada Government of Canada
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference379 articles.
1. Charting the Travels of Copper in Eukaryotes from Yeast to Mammals;Nevitt;Biochim. Biophys. Acta (BBA)-Mol. Cell Res.,2012 2. Dietary Reference Intakes;Trumbo;J. Am. Diet. Assoc.,2001 3. Moshfegh, A.J., Goldman, J.D., Rhodes, D.G., and Friday, J.E. (2023, November 11). Usual Nutrient Intake from Food and Beverages, by Gender and Age, What We Eat In America, NHANES 2017-March 2020 Prepandemic, Available online: www.ars.usda.gov/nea/bhnrc/fsrg. 4. Copper Deficiency Anemia;Myint;Ann. Hematol.,2018 5. Grochowski, C., Blicharska, E., Baj, J., Mierzwińska, A., Brzozowska, K., Forma, A., and Maciejewski, R. (2019). Serum Iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review. Molecules, 24.
|
|